Cargando…
Caveolin-1 Expression in Thyroid Neoplasia Spectrum: Comparison of Two Commercial Antibodies
We evaluated caveolin-1 expression in the human thyroid neoplasia spectrum with the aim of examining differences in expression as detected by two anti-caveolin-1 antibodies, and secondly, to investigate the association of caveolin-1 expression levels with aggressive papillary thyroid carcinoma (PTC)...
Autores principales: | Janković, Jelena, Paskaš, Svetlana, Marečko, Ilona, Božić, Vesna, Cvejić, Dubravka, Savin, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810771/ https://www.ncbi.nlm.nih.gov/pubmed/23023191 http://dx.doi.org/10.3233/DMA-2012-00934 |
Ejemplares similares
-
Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration
por: Marečko, Ilona, et al.
Publicado: (2014) -
Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum
por: Ignjatović Jocić, Valentina, et al.
Publicado: (2023) -
Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature
por: Dunđerović, Duško, et al.
Publicado: (2015) -
Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement
por: Rončević, Jelena, et al.
Publicado: (2022) -
Comparison of Dissolution Profiles and Serum Concentrations of Two Lamotrigine Tablet Formulations
por: Lalic, Mladena, et al.
Publicado: (2012)